Robert L. Wilensky, M.D.

faculty photo
Emeritus Professor CE of Medicine
Director Interventional Fellowship Program, University of Pennsylvania Health System
Department: Medicine

Contact information
Penn Medicine
Division of Cardiovascular Medicine
Perelman Center for Advanced Medicine
11th Floor, South Pavilion
3400 Civic Center Blvd
Philadelphia, PA 19104
Office: (215) 615-3060
Fax: 215-349-5894
B.A. (Physiology)
University of Colorado , 1976.
University of Amsterdam, 1985.
Permanent link
> Perelman School of Medicine   > Faculty   > Details

Description of Clinical Expertise

Percutaneous coronary intervention
Cardiac catheterization
Acute coronary syndromes

Selected Publications

Schaar JA, Muller JE, Falk E, Virmani R, Fuster V,Serruys PW, Colombo A, Stefanadis C, Casscells W, Moreno PR, Maseri A, van der Steen AFW: Terminology for high-risk and vulnerable coronary artery plaques. European Heart Journal 25: 1-6, 2004.

Laskey WK, Selzer F, Cohen H, Holmes D, Wilensky R, Williams D, Detre K: Temporal variation in fatal percutaneous coronary intervention outcomes: A report from the NHLBI Dynamic Registry. Am Heart J 150: 569, 2005.

Hirshfeld JW, Wilensky RL: Drug eluting stents are here - now what? Implications for clinical practice and health care costs. Cleveland Clinic Journal. In Press, 2004.

Naimark WA, Lepore JJ, Klugherz BD, Wang Z, Guy TS, Osman H, Moainie SL, Gorman RC, Gorman JH III, Palasis M, Parmacek MS, Wilensky RL. : Adenovirus-catheter compatibility increases gene expression. Hum Gene Ther 14: 161-167, 2003.

Mainigi SK, Goldberg LR, Sasseen BM, See VY, Wilensky RL. : Relative contributions of intimal hyperplasia and vascular remodeling in early cardiac transplant mediated coronary artery disease. Am J. Cardiol 91: 293-296, 2003.

Meneveau NF, Klugherz BD, Chaquor B, Golden M, Jouille MM, Macarak E, Weisz PB, Wilensky RL. : Separate and combined effects of local and continuous intravenous administration and beta-cyclodextrin tetradecasulfate on intimal hyperplasia after angioplasty in porcine coronary arteries. J Cardiovasc Pharmacol Therapeut 8: 53-60, 2003.

See VY, DeNofrio D, Goldberg L, Chang G, Sasseen B, Kolansky DM, Pickering F, Kao A, Loh E, Wilensky RL. : Effect of atorvastatin on post-cardiac transplant increase in low-density lipoprotein and cholesterol levels reduces development of intimal hyperplasia and ameliorates progression of endothelial dysfunction. Am J Cardiol 92: 11-15, 2003.

Perlstein I, Connolly JM, Cui X, Song C, Quanyi Li, Jones PL, Lu Z, DeFelice S, Klugherz B, Wilensky R, Levy RJ. : DNA Delivery from an intravascular stent with a denatured collagen-polylactic-polyglycolic acid controlled release coating: mechanisms of enhanced transfection, in press. Gene Therapy 2003.

Kizer JR, Muttreja MR, Matthei WH, McConnell J, Nardone H, Sonel AF, Keane MG, Wilensky RL. : Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention, in press. Eur Heart J 2003.

Wilensky RL, Klugherz BD. : Coronary artery disease and congestive heart failure. A Clinician’s guide to ambulatory diagnosis and treatment. Heart Failure. Jessup M, Loh E (eds.). Humana Press, Totowa Page: 131-148, 2003.

back to top
Last updated: 04/25/2022
The Trustees of the University of Pennsylvania